Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB
Open Access
- 29 March 2020
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 18 (4) , 180
Abstract
α-Conotoxin TxIB specifically blocked α6/α3β2β3 acetylcholine receptors (nAChRs), and it could be a potential probe for studying addiction and other diseases related to α6/α3β2β3 nAChRs. However, as a peptide, TxIB may suffer from low stability, short half-life, and poor bioavailability. In this study, cyclization of TxIB was used to improve its stability. Four cyclic mutants of TxIB (cTxIB) were synthesized, and the inhibition of these analogues on α6/α3β2β3 nAChRs as well as their stability in human serum were measured. All cyclized analogues had similar activity compared to wild-type TxIB, which indicated that backbone cyclization of TxIB had no significant effect on its activity. Cyclization of TxIB with a seven-residue linker improved its stability significantly in human serum. Besides this, the results showed that cyclization maintained the activity of α-conotoxin TxIB, which is conducive to its future application.Keywords
Funding Information
- National Natural Science Foundation of China (81660585, 81872794)
- the 111 Project (D20010)
This publication has 47 references indexed in Scilit:
- Positional Scanning Mutagenesis of α-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for α6/α3β2β3 and α3β2 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 2013
- Characterization of a Novel α-Conotoxin from Conus textile That Selectively Targets α6/α3β2β3 Nicotinic Acetylcholine ReceptorsJournal of Biological Chemistry, 2013
- α6* Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience CircuitJournal of Neuroscience, 2012
- Cyclisation Increases the Stability of the Sea Anemone Peptide APETx2 but Decreases Its Activity at Acid-Sensing Ion Channel 3Marine Drugs, 2012
- Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersBiochemical Pharmacology, 2011
- Nicotinic Acetylcholine Receptor Signaling in Tumor Growth and MetastasisJournal of Oncology, 2011
- Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted TherapyJournal of Medicinal Chemistry, 2011
- Improving Metabolic Stability by Glycosylation: Bifunctional Peptide Derivatives That Are Opioid Receptor Agonists and Neurokinin 1 Receptor AntagonistsJournal of Medicinal Chemistry, 2009
- Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptorsActa Pharmacologica Sinica, 2009
- Peptide Cyclization and Cyclodimerization by CuI-Mediated Azide−Alkyne CycloadditionThe Journal of Organic Chemistry, 2009